Shares of Surgery Partners Inc (NASDAQ:SGRY) have received a consensus rating of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $15.50.
SGRY has been the topic of several recent analyst reports. Royal Bank of Canada reiterated a “buy” rating and set a $14.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 13th. Benchmark upgraded shares of Surgery Partners from a “hold” rating to a “buy” rating and set a $14.00 price objective on the stock in a research report on Monday, April 27th. UBS Group lifted their price objective on shares of Surgery Partners from $12.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, February 20th. BidaskClub upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, May 21st. Finally, ValuEngine cut shares of Surgery Partners from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 2nd.
NASDAQ SGRY traded down $2.35 on Monday, reaching $12.36. 55,505 shares of the stock were exchanged, compared to its average volume of 821,383. Surgery Partners has a one year low of $4.00 and a one year high of $19.74. The firm has a market capitalization of $714.83 million, a PE ratio of -6.05 and a beta of 3.45. The company’s 50-day simple moving average is $12.01 and its two-hundred day simple moving average is $13.14. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.84.
Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, May 11th. The company reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.62) by $0.28. Surgery Partners had a negative net margin of 4.38% and a negative return on equity of 2.21%. The company had revenue of $441.00 million for the quarter, compared to analysts’ expectations of $377.50 million. Sell-side analysts forecast that Surgery Partners will post -1.34 earnings per share for the current fiscal year.
Several institutional investors and hedge funds have recently modified their holdings of SGRY. Bank of Montreal Can raised its holdings in shares of Surgery Partners by 32.4% in the fourth quarter. Bank of Montreal Can now owns 3,865 shares of the company’s stock valued at $61,000 after acquiring an additional 946 shares in the last quarter. Two Sigma Advisers LP bought a new position in Surgery Partners in the first quarter worth about $76,000. Citigroup Inc. increased its holdings in shares of Surgery Partners by 247.4% during the first quarter. Citigroup Inc. now owns 18,713 shares of the company’s stock valued at $122,000 after acquiring an additional 13,327 shares in the last quarter. Deutsche Bank AG increased its holdings in shares of Surgery Partners by 164.8% during the first quarter. Deutsche Bank AG now owns 21,326 shares of the company’s stock valued at $139,000 after acquiring an additional 13,273 shares in the last quarter. Finally, Aigen Investment Management LP acquired a new position in shares of Surgery Partners during the first quarter valued at about $175,000. 93.05% of the stock is owned by hedge funds and other institutional investors.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
See Also: Liquidity
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.